Related Experiment Videos
AntiArthritis Therapies 2005
1Discovery Bioscience, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough LE11 5RH, Leicestershire, UK. Martin.Braddock@astrazeneca.com
Expert Opinion on Investigational Drugs
|May 11, 2005
Summary
This meeting focused on pharmaceutical drug discovery and development, covering preclinical research and the use of launched drugs for arthritis treatment. Discussions involved optimizing compounds and exploring current therapeutic strategies.
Area of Science:
- Pharmaceutical Sciences
- Drug Discovery and Development
Background:
- Meeting convened approximately 35 delegates from the pharmaceutical industry.
- Focused on interactive discussions regarding drug discovery and development.
Framework:
- Covered a broad spectrum of activities within the drug development pipeline.
- Included preclinical studies and post-launch drug utilization.
Implementation:
- Discussed optimization of preclinical compounds.
- Explored current applications of launched drugs in arthritis therapy.
Implications:
- Facilitated knowledge exchange on advancing pharmaceutical R&D.
- Addressed challenges and opportunities in bringing drugs to market for conditions like arthritis.